Topical nepafenac as a treatment for CME
US FDA approves Zeiss MEL 90 excimer laser for myopia, hyperopia and mixed astigmatism
The laser integrates into the Corneal Refractive Workflow alongside the Visumax 800 and SMILE pro software
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Bausch + Lomb launches its enVista Aspire monofocal and toric intraocular lenses in the European Union
The launch follows a CE Mark received in late 2024
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Retinopathy of prematurity study demonstrates noninferiority of combination microdrops compared to standard mydriatics
The authors investigated systemic adverse events associated with commercial mydriatics administered during retinopathy of prematurity (ROP) screening
ViGeneron receives rare paediatric disease designation from US FDA for retinitis pigmentosa gene therapy candidate VG901
ViGeneron, based in Munich, also received approval for dose escalation in the ongoing phase 1b clinical trial
